Advantage Investment Management »

Horizon Therapeutics shares owned by Advantage Investment Management

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Advantage Investment Management from 13F filings

Historical chart of Advantage Investment Management investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Advantage Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Advantage Investment Management

Quarter filed Position value Share count Share price at filing
2019-09-30 $214k 7.9k 27.18
2019-06-30 $189k 7.9k 24.00

More positions owned by Advantage Investment Management

Ishares Tr usa min vo (USMV)
Victory Portfolios Ii Cemp Us 500 Enha etf (CFO)
Spdr Series Trust aerospace def (XAR)
Ark Etf Tr web x.o etf (ARKW)
Vanguard Sht Term Govt Bond ETF (VGSH)
Vanguard Short Term Corporate Bond ETF (VCSH)
Victory Cemp Us Eq Income etf (CDC)
iShares S&P SmallCap 600 Index (IJR)
Health Care SPDR (XLV)
Technology SPDR (XLK)
Invesco Qqq Trust Series 1 (QQQ)
Consumer Staples Select Sect. SPDR (XLP)
Absolute Shs Tr wbi pwr fctr etf (WBIY)
Financial Select Sector SPDR (XLF)
Energy Select Sector SPDR (XLE)

View all positions for Advantage Investment Management

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics